CareDx, Inc. Hits New 52-Week High of $24.82, Up 55.83%

CareDx, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 24.82 on June 16, 2026. This achievement underscores the company's robust performance, particularly in the context of its impressive one-year growth of 55.83%, significantly outpacing the S&P 500's 24.5% return. The company has demonstrated remarkable financial metrics, including a substantial operating profit growth of 426.01% reported on March 26. CareDx has consistently delivered positive results over the last three consecutive quarters, showcasing a strong operational cash flow of USD 72.95 million. Additionally, the pre-tax profit for the most recent quarter reached USD 3.38 million, reflecting a growth of 204.24%, while net profit also saw a notable increase of 203.07% to USD 3.41 million. With a market capitalization of USD 859 million and high institutional holdings at 100%, CareDx, Inc. continues to solidify its position in the market, demonstrating resilience and consistent returns over the past three years.